Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

US proposes tighter rules on clinical trial reporting

If approved, data from around 650 additional studies per year will be released

- PMLiVE

EU approval for Gilead’s hep C combo Harvoni

Another boost for the company’s fast-growing Sovaldi franchise

- PMLiVE

Johan Heylen leaves GSK for Ablynx

He joins Nanobody specialist as chief commercial officer

- PMLiVE

AZ seeks leg up in antiplatelet market with Brilinta antidote

Reversal agent has been developed by company's biotech subsidiary Medimmune

- PMLiVE

Merck Serono brings electronic MS device to six more countries

RebiSmart works alongside the company's MSdialog web-based software

- PMLiVE

MSF disputes Tufts’ estimates on cost of drug development

Center for the Study of Drug Development says it takes up to $2.5bn to bring a drug to market

- PMLiVE

NICE wants more info on Novartis’ Xolair in chronic hives

Says company must provide more data on the drug's effectiveness

- PMLiVE

PCSK9 inhibitor alirocumab works in statin-intolerance

Sanofi and Regeneron’s drug impresses at American Heart Association meeting

Jacques Dumas joins Nosopharm scientific advisory board

French biotech's appointments also include Dominique Breilh

- PMLiVE

Charity coalition pledges millions for brain disease research

Will invest £30m developing candidates for neurodegenerative conditions

- PMLiVE

The impact of the US Sunshine Act

A new dawn begins for pharma’s payments to doctors in the US

- PMLiVE

Reckitt to spin-off pharma unit as Indivior

Demerged business will focus on opioid dependence product Suboxone

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links